ChemE Briefs

Welcome to ChemE Briefs, a place to find quick notes and posts from the faculty, students, staff and alumni of the Department of Chemical Engineering at the University of Virginia.


    Trigon Engineering Society Invites ChemE Department Chair to Speak at Annual Award Dinner

    February 07, 2020
    Epling250_2869.jpg

    Professor and chair of the Department of Chemical Engineering at the University of Virginia Bill Epling was the invited speaker at the Thomas E. Hutchinson Award Dinner on Jan. 25, presented by the Trigon Engineering Society. In his remarks, Epling highlighted the uniqueness of the UVA School of Engineering, the importance of teaching and leadership, and the challenges today’s students will face as engineers of the future.

    Keith WiIliams, an associate professor in the Department of Electrical and Computer Engineering, won the Hutchinson Award, which is given annually by the Trigon Society for “Outreach to students, enthusiastic lectures, obvious love of teaching, and contributions to the Engineering School.” Trigon coordinates the selection process, but nominations and voting for the award are open to all engineering students.

    Last year’s winner was chemical engineering’s own Rachel Letteri.


    UVA ChemE Alumnus to Accept Industry Award for Team’s Work on Important Cancer Drug

    February 01, 2020
    Hunter_0805 d_250.jpg

    Alan Hunter, a 2002 chemical engineering Ph.D. graduate who studied with Lawrence R. Quarles Professor Giorgio Carta at the University of Virginia, will represent AstraZeneca as the recipient of the 2020 Division of Biochemical Technology of the American Chemical Society (known as ACS BIOT) Industrial Biotechnology Award at the division’s 2020 meeting in Philadelphia. The award honors AstraZeneca’s Lumoxiti process chemistry, manufacturing and controls team, led by Hunter, for its development and scale up of the process used to produce Lumoxiti, an important new biologic cancer drug. Another Carta lab Ph.D. graduate, Timothy Pabst, was also a member of AstraZeneca’s award-winning team.

    As a student and member of Carta’s bioseparations engineering lab, Hunter studied process chromatography and protein mass transport. He has worked in the biopharmaceutical industry for more than 15 years, beginning his career in 2004 at Pfizer in the global biologics group. In 2009, he moved to AstraZeneca, where he is director of the biopharmaceutical development purification process sciences group.

    Hunter stays involved with the department. He gives an annual lecture on regulatory aspects of biopharmaceutical manufacturing in Carta’s CHE4448 Bioseparation Engineering course. In 2019, he was the keynote speaker at the inaugural CHEERS, the Chemical Engineering Research Symposium.

    Carta said Hunter and Pabst collaborate with his lab on research aimed at better understanding and improving biopharmaceutical manufacturing and have published a number of joint papers.


    Hongxi Luo Will Go to 2020 NAMS Meeting on Student Fellowship Award

    January 26, 2020
    Luo_250.jpg

    Chemical engineering Ph.D. student Hongxi Luo was selected to receive the NAMS Student Fellowship Award.

    The award is given each year by the North American Membrane Society (NAMS) to “outstanding graduate students in the membrane science and technology area.” The award will support Luo’s participation in the society’s 2020 meeting in May in Tempe, Ariz.

    Luo is a member of the polymer member research group led by assistant professor Geoffrey Geise.


    UVA ChemE Professor’s Agricultural Biotech Startup Reaps Competitive Grant from Virginia Catalyst

    January 13, 2020

    Lytos Technologies, an early-stage startup company co-founded by chemical engineering associate professor Bryan Berger, and its UVA and Virginia Tech partners, have received a $500,000 grant from Virginia Catalyst to continue work on safe, effective alternatives to chemical pesticides for agricultural applications.

    UVAEng_CHE_berger.jpg

    Virginia Catalyst is a non-profit corporation funded by the Virginia General Assembly and several of the state’s leading public universities, including the University of Virginia. Its competitive Grant Funding Program supports collaborative life- and bioscience research and commercialization of new innovations with the potential to address large, unmet needs for improving human health; create high-value jobs in Virginia; and strengthen the state’s competitive advantage in life science technologies, according to a news release from the Office of the Governor.

    The project Lytos is working on with its university partners, “Design and implementation of green, enzymatic biofungicides for pre- and post-harvest crop protection,” is one of six collaborations to win a grant in the organization’s 10th and latest round of funding. This round’s grants total $3.3 million.

    Berger co-founded Lytos with his former student, Evan Eckersley, at UVA. The award will support their ongoing efforts to develop and commercialize effective “green” biocides as well as targeted applications for pre- and post-harvest crop protection. Lytos works with Virginia wine grape growers, Berger said, to find organic biopesticides that outperform traditional chemicals.

    “In working directly with local wineries, we will be able to deliver products that will contribute to the growing sustainable, organic wine movement,” he said.


    ChemE Professor Celebrates With Former Colleagues Being Honored for ‘Doing a World of Good’

    December 23, 2019

    University of Virginia Chemical Engineering Professor of Practice Michael L. King was honored to be invited to the American Institute of Chemical Engineers’ “Doing a World of Good” gala in New York City in December. At the gala, the institute recognized Merck & Co. and the company’s chief executive officer, Ken Frazier, with a Doing a World of Good award. King worked at Merck for 32 years, retiring as senior vice president science and technology, before joining UVA’s chemical engineering faculty.

    “It was a wonderful event and noted the many contributions that chemical engineers have made at Merck in the development and commercialization of important drugs and vaccines,” King said.

    AICHE-70 mike ken and mike 920.jpg

    Pictured from left: Michael Thien, Merck senior vice president; Ken Frazier, Merck CEO; and Michael L. King, UVA chemical engineering professor of practice.


    Graduate Student From Lazzara Lab Wins Presentation Award

    October 23, 2019
    EvanDay-LazzaraLab250.jpg

    Evan Day, a student in Associate Professor Matt Lazzara’s lab, is the 2019 winner of the W.H. Peterson Oral Presentation Award given by the Division of Biochemical Technology of the American Chemical Society. The award is for his presentation on work that led to the creation of a new tool to evaluate the in vivo (taking place in a living organism) efficacy of targeted inhibitors for cancer. Evan presented the research, titled “Engineering a bioluminescence-based protein kinase reporter for in vivo, longitudinal studies of receptor tyrosine kinase inhibitor response,” at the division’s annual meeting in Orlando, Fla., last spring. The award will be presented at the American Chemical Society Biochemical Technology Division 2020 annual meeting, which will be held in March in Philadelphia.

    “The deployment of this tool will lead to better preclinical in vivo data, and greatly reduce the numbers of animals needed to evaluate drug efficacy, at least for a particular class of drugs,” Professor Lazzara said. “The basic design principle behind it may eventually be adapted for use with other types of drugs.”


    Ph.D. Student Lands National Science Foundation INTERN Funding for Research at Merck

    October 23, 2019
    Upright Nate250.jpg

    Nate Sallada, a Ph.D. student in Associate Professor Bryan Berger’s lab, recently received a National Science Foundation Non-Academic Research Internships for Graduate Students INTERN award. INTERN opportunities provide supplemental funding for students already supported by an active National Science Foundation grant, allowing them to pursue activities and training that complements their academic research experience.

    The funding will support collaborative work with researchers at Merck & Co., which follows up on previous work with the pharmaceutical company that is pending publication. The research involves developing new, protein-based formulating agents to improve drug delivery for the treatment of diseases. Nate will work at Merck in winter and spring of 2020 with Matthew Lamm, director of preformulation at Merck, to further investigate the mechanism of improved drug delivery using the designed proteins developed at UVA.


    Professor Lazzara Awarded NIH Cancer Systems Biology Grant

    August 30, 2019
    Lazzara_0056_250.jpg

    Associate Professor Matt Lazzara was awarded a new five-year U01 grant from the National Cancer Institute to apply systems biology methods for the rational design of combination therapy for pancreatic cancer. The award was made through the institute’s funding opportunity for Emerging Questions in Cancer Systems Biology and establishes the Lazzara Lab as a member of the NCI Cancer Systems Biology Consortium. Lazzara and his team will collaborate with investigators at the UVA School of Medicine, University of Pennsylvania and University of Delaware on the project.


    Geise Research Group Paper is Editors’ Choice

    August 29, 2019

    geise group

    The Geise Research Group recently published a paper that was selected as an American Chemical Society Editors’ Choice article. The research features the work of graduate students Hongxi Luo (back row, second from left) and Kevin Chang (back row, far left) along with undergraduate Kevin Bahati (front row, far right), who is an Undergraduate Student Opportunities in Academic Research (USOAR) researcher. The paper, titled “Engineering Selective Desalination Membranes via Molecular Control of Polymer Functional Groups,” describes a strategy for increasing the effectiveness of water desalination by improving membrane selectivity. The approach is based on controlling chemical functional group position within the polymer that is used to make the desalination membrane. Also pictured above are graduate students Saringi Agata (back row, right), YuanYuan Ji (front row, second from left) and Patrick McCormack (front row, second from right), and Prof. Geoff Geise (front row, far left).


    Chemical and Biomedical Engineering Students’ Summer Work Aims to Prevent Spread of Infection

    August 22, 2019
    Allie_and_Molly250.jpg

    This summer, rising third-year chemical engineering major Molly Caveney (right) and Allie Boboltz, a biomedical engineering major, worked on using engineered proteins to break down biofilms and prevent the spread of infection, with chemical engineering associate professor Bryan Berger.

    “The benefit of engineered proteins is that they are both effective in breaking down biofilms and organically derived, meaning that they won’t contribute to antimicrobial resistance,” Allie said. “We have been working this summer to isolate, express and purify proteins in E. Coli bacteria that could potentially be used against biofilms. This involves cloning my gene of interest into a bacterial plasmid, then using the plasmid to over-express my target protein in E. Coli. My next step is to apply these proteins to biofilms and observe the protein’s activity on the biofilm.”

    When they were not in the lab, Molly and Allie went on ice cream tours throughout the Charlottesville area.